Biocon’s push in a crowded segment is viewed as interesting considering that in the last two years, the company has consciously moved out of products that have seen fierce competition. Money Control, 3 weeks ago
Biocon partners with Eisai to markets its anti-ulcer drug in India - Money Control, 4 weeks ago
* Nintendo most traded stock by turnover on strong Switchsales * Nikkei Jasdaq rises for 19th day By Ayai Tomisawa TOKYO, March 8 (Reuters) - Japan's Nikkei share averageeased slightly for the fourth consecutive day on Wednesday, asinvestors took caution ...Sify, 1 month ago
on your WebpageAdd Widget >Get your members hooked!